Research programme: Fas inhibitors - Apoxis
Latest Information Update: 23 Nov 2006
At a glance
- Originator Apoxis
- Class
- Mechanism of Action Apoptosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 02 Jul 2003 Preclinical trials in Autoimmune disorders in Switzerland (unspecified route)